Table 1.
Baseline Characteristics and Treatment Results.
| Baseline minimum | Baseline maximum | Baseline Mean ± SD | End of study Mean ± SD | p | |
|---|---|---|---|---|---|
| Age (years) | 39 | 80 | 57.2 ± 9.6 | ||
| BMI (kg/m2) | 15.74 | 30.74 | 22.8 ± 3.3 | 22.7 ± 3.1 | .47 |
| AMS score | 23 | 77 | 52.3 ± 12.6 | 40.3 ± 11.6 | <.001 |
| IPSS score | 0 | 30 | 8.8 ± 8.6 | 7.4 ± 7.3 | .039 |
| IIEF-5 | 1 | 25 | 6.3 ± 6.7 | 8.6 ± 7.0 | .049 |
| Residual urine volume (mL) | 0 | 80 | 10.6 ± 20.3 | 6.0 ± 14.2 | .11 |
| Prostate volume (mL) | 4.5 | 34 | 16.7 ± 6.9 | 17.1 ± 5.8 | .32 |
| PSA (ng/dL) | 0.19 | 1.9 | 0.81 ± 0.42 | 1.0 ± 0.61 | .009 |
| Total testosterone (ng/mL) | 1.0 | 8.9 | 5.1 ± 1.8 | 11.5 ± 4.4 | <.001 |
| Free testosterone (pg/mL) | 0.60 | 10.8 | 6.5 ± 2.4 | 20.5 ± 9.2 | <.001 |
Note. BMI = body mass index; AMS = Aging Male Symptom; IPSS = International Prostate Symptoms Score; IIEF-5 = International Index of Erectile Function–5; PSA = prostate-specific antigen.